Sign in to view content

Effect of Fluocinolone Acetonide 0.2µg/day (ILUVIEN®) Implant on the Decision to Drive in Patients With Differential Control of DME

Seenu M. Hariprasad, MD

Video
Published 2018

Related

Efficacy, Durability, and Safety of Faricimab in DME: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2022
Use of Suprachoroidal Space for Treatment of Peripheral Retinal Breaks
Shohista Saidkasimova, FRCOPhth
On Demand Cases, Courses, and Papers
2018
Applying the DRCR.net Anti-VEGF Treatment Algorithm for Proliferative Diabetic Retinopathy: Neovascular Outcomes Over 2 Years
Christina Joy Flaxel, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more